Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain

Eva J. Brandl; Arun K. Tiwari; Nabilah I. Chowdhury; Clement C. Zai; Jeffrey A. Lieberman; Herbert Y. Meltzer; James L. Kennedy; Daniel J. Müller

doi:10.2217/pgs.13.247

Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain

Eva J. Brandl, Arun K. Tiwari, Nabilah I. Chowdhury, Clement C. Zai, Jeffrey A. Lieberman, Herbert Y. Meltzer, James L. Kennedy, Daniel J. Müller^*

^*Corresponding author for this work

Psychiatry and Behavioral Sciences

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Aim: GLP-1 plays a key role in glucose metabolism and influences antipsychotic-induced weight gain (AIWG). Our study is the first to investigate the encoding gene, GCG, and the GLP-1 receptor gene, GLP1R, and association with AIWG. Materials & methods: In 216 schizophrenic patients treated with antipsychotics for up to 14 weeks, we investigated four GCG and 33 GLP1R polymorphisms. Statistical analyses were conducted using SPSS, Haploview 4.2, UNPHASED 3.1.4 and the R-package mbmdr. Results: We observed association of rs13429709 near GCG with AIWG (p_corr = 0.044) in patients of European ancestry receiving olanzapine or clozapine (n = 87). We also found significant gene-gene interaction between rs13429709 and rs2268639 in GLP1R. Only nonsignificant trends were observed for GLP1R polymorphisms with AIWG. Conclusion: We found significant association of rs13429709 with AIWG. Although there was no significant finding for GLP1R, the observed trends and interaction suggest this to be an interesting gene for further examination.

Original language	English (US)
Pages (from-to)	423-431
Number of pages	9
Journal	Pharmacogenomics
Volume	15
Issue number	4
DOIs	https://doi.org/10.2217/pgs.13.247
State	Published - Mar 2014

Keywords

GCG
GLP1R
antipsychotic-induced weight gain
clozapine
olanzapine
pharmacogenetics

ASJC Scopus subject areas

Genetics
Molecular Medicine
Pharmacology

Access to Document

10.2217/pgs.13.247

Cite this

@article{68c335889cd945dca59d6524eee8cbdc,

title = "Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain",

abstract = "Aim: GLP-1 plays a key role in glucose metabolism and influences antipsychotic-induced weight gain (AIWG). Our study is the first to investigate the encoding gene, GCG, and the GLP-1 receptor gene, GLP1R, and association with AIWG. Materials & methods: In 216 schizophrenic patients treated with antipsychotics for up to 14 weeks, we investigated four GCG and 33 GLP1R polymorphisms. Statistical analyses were conducted using SPSS, Haploview 4.2, UNPHASED 3.1.4 and the R-package mbmdr. Results: We observed association of rs13429709 near GCG with AIWG (pcorr = 0.044) in patients of European ancestry receiving olanzapine or clozapine (n = 87). We also found significant gene-gene interaction between rs13429709 and rs2268639 in GLP1R. Only nonsignificant trends were observed for GLP1R polymorphisms with AIWG. Conclusion: We found significant association of rs13429709 with AIWG. Although there was no significant finding for GLP1R, the observed trends and interaction suggest this to be an interesting gene for further examination.",

keywords = "GCG, GLP1R, antipsychotic-induced weight gain, clozapine, olanzapine, pharmacogenetics",

author = "Brandl, {Eva J.} and Tiwari, {Arun K.} and Chowdhury, {Nabilah I.} and Zai, {Clement C.} and Lieberman, {Jeffrey A.} and Meltzer, {Herbert Y.} and Kennedy, {James L.} and M{\"u}ller, {Daniel J.}",

year = "2014",

month = mar,

doi = "10.2217/pgs.13.247",

language = "English (US)",

volume = "15",

pages = "423--431",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Taylor and Francis Ltd.",

number = "4",

}

TY - JOUR

T1 - Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain

AU - Brandl, Eva J.

AU - Tiwari, Arun K.

AU - Chowdhury, Nabilah I.

AU - Zai, Clement C.

AU - Lieberman, Jeffrey A.

AU - Meltzer, Herbert Y.

AU - Kennedy, James L.

AU - Müller, Daniel J.

PY - 2014/3

Y1 - 2014/3

N2 - Aim: GLP-1 plays a key role in glucose metabolism and influences antipsychotic-induced weight gain (AIWG). Our study is the first to investigate the encoding gene, GCG, and the GLP-1 receptor gene, GLP1R, and association with AIWG. Materials & methods: In 216 schizophrenic patients treated with antipsychotics for up to 14 weeks, we investigated four GCG and 33 GLP1R polymorphisms. Statistical analyses were conducted using SPSS, Haploview 4.2, UNPHASED 3.1.4 and the R-package mbmdr. Results: We observed association of rs13429709 near GCG with AIWG (pcorr = 0.044) in patients of European ancestry receiving olanzapine or clozapine (n = 87). We also found significant gene-gene interaction between rs13429709 and rs2268639 in GLP1R. Only nonsignificant trends were observed for GLP1R polymorphisms with AIWG. Conclusion: We found significant association of rs13429709 with AIWG. Although there was no significant finding for GLP1R, the observed trends and interaction suggest this to be an interesting gene for further examination.

AB - Aim: GLP-1 plays a key role in glucose metabolism and influences antipsychotic-induced weight gain (AIWG). Our study is the first to investigate the encoding gene, GCG, and the GLP-1 receptor gene, GLP1R, and association with AIWG. Materials & methods: In 216 schizophrenic patients treated with antipsychotics for up to 14 weeks, we investigated four GCG and 33 GLP1R polymorphisms. Statistical analyses were conducted using SPSS, Haploview 4.2, UNPHASED 3.1.4 and the R-package mbmdr. Results: We observed association of rs13429709 near GCG with AIWG (pcorr = 0.044) in patients of European ancestry receiving olanzapine or clozapine (n = 87). We also found significant gene-gene interaction between rs13429709 and rs2268639 in GLP1R. Only nonsignificant trends were observed for GLP1R polymorphisms with AIWG. Conclusion: We found significant association of rs13429709 with AIWG. Although there was no significant finding for GLP1R, the observed trends and interaction suggest this to be an interesting gene for further examination.

KW - GCG

KW - GLP1R

KW - antipsychotic-induced weight gain

KW - clozapine

KW - olanzapine

KW - pharmacogenetics

UR - http://www.scopus.com/inward/record.url?scp=84896334203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896334203&partnerID=8YFLogxK

U2 - 10.2217/pgs.13.247

DO - 10.2217/pgs.13.247

M3 - Article

C2 - 24624910

AN - SCOPUS:84896334203

SN - 1462-2416

VL - 15

SP - 423

EP - 431

JO - Pharmacogenomics

JF - Pharmacogenomics

IS - 4

ER -

Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this